Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

View:
Post by KimKWest on Nov 26, 2020 9:44am

Why tho?

Any insights on why we are trending up? Let's have a real discussion plzzz..no more BS.
Comment by RiskyBiz928 on Nov 26, 2020 9:49am
It has to be the psychedelics. The covid play seems to have stalled.
Comment by KimKWest on Nov 26, 2020 9:51am
Any specific moves or news in the pyschedelics industry, i cant find an specific event..MMED shot up earlier this week but now seems to be back down..oddly.
Comment by Kabron on Nov 26, 2020 9:53am
Maybe they will give an update on the trials...
Comment by KimKWest on Nov 26, 2020 9:57am
I really hope so, but like others have said we got Moderna, Pfizer, etc. dominating the headlines with supposed vaccines, so i doubt RVV will make an impact with news on "treatment" trials. I think we more of psychedlics update. Lets see how mgmt plays this, either way i like were we are going and may sell soon to make a quickie.
Comment by RiskyBiz928 on Nov 26, 2020 9:56am
No specific event but in the article that came out yesterday: Traditional medicine may soon see itself transformed by the $100 billion market opportunity that psychedelics can provide. Its the potential.
Comment by IceColdBeer on Nov 26, 2020 10:02am
Wrong and it's not a play.  You do realize people go into the hospital with pneumonia right?  You do also understand what happens to the lungs there?  This is not a covid play, it would be one of the many conditions it can help with though. The shroom side will also not hurt at all.  This is a solid company with many irons in the fire.
Comment by RiskyBiz928 on Nov 26, 2020 10:09am
A 'play' a 'gig' an 'avenue' - who cares what you call it. All I am saying is that the covid side has stalled until some trial results come out. Thus, the shroom buzz is sustaining this surge. Hopefully it holds and then will be bolstered by some solid covid findings. 
Comment by KimKWest on Nov 26, 2020 10:14am
The shroom buzz will not hold in the short term hun. We are years, many years from a shroom boom like marijuana. Agree we need to hold onto hope for covid related news at the moment :)
Comment by KimKWest on Nov 26, 2020 10:12am
You do understand that we need more expsoure right? And you do realize that nobody cares covid treatments at the moment because of the vaccine buzz? And you do understand that the SP is dropping now as predicted? And you do understand that right?
Comment by Towser7 on Nov 26, 2020 3:01pm
As a COVID play, the longer the results take to come out for bucillamine the less value investors might see in the company in the short term because of the vaccines.  To your point therapeutics haven't been making the news much and they are still important for long haulers.